Revvity Board Declares Quarterly Dividend
Revvity (NYSE: RVTY) announced that its Board of Directors has declared a quarterly dividend of $0.07 per share of common stock. The dividend will be paid on May 9, 2025, to shareholders of record as of the close of business on April 18, 2025.
Revvity (NYSE: RVTY) ha annunciato che il suo Consiglio di Amministrazione ha dichiarato un dividendo trimestrale di $0,07 per azione di azioni ordinarie. Il dividendo sarà corrisposto il 9 maggio 2025 agli azionisti registrati alla chiusura delle attività il 18 aprile 2025.
Revvity (NYSE: RVTY) anunció que su Junta Directiva ha declarado un dividendo trimestral de $0.07 por acción de acciones ordinarias. El dividendo se pagará el 9 de mayo de 2025 a los accionistas registrados al cierre de operaciones el 18 de abril de 2025.
Revvity (NYSE: RVTY)는 이사회가 보통주 1주당 $0.07의 분기 배당금을 선언했다고 발표했습니다. 배당금은 2025년 5월 9일에 지급되며, 2025년 4월 18일 영업 종료 시점에 주주로 등록된 분에게 지급됩니다.
Revvity (NYSE: RVTY) a annoncé que son Conseil d'Administration a déclaré un dividende trimestriel de 0,07 $ par action ordinaire. Le dividende sera payé le 9 mai 2025 aux actionnaires inscrits à la clôture des marchés le 18 avril 2025.
Revvity (NYSE: RVTY) hat bekannt gegeben, dass der Vorstand eine Vierteljahresdividende von 0,07 $ pro Stammaktie erklärt hat. Die Dividende wird am 9. Mai 2025 an die Aktionäre ausgezahlt, die zum Geschäftsschluss am 18. April 2025 eingetragen sind.
- Maintains consistent quarterly dividend distribution, showing financial stability
- Continues to provide regular income stream to shareholders
- None.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2023 revenue of more than
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123322921/en/
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Source: Revvity
FAQ
What is the amount of Revvity's quarterly dividend for May 2025?
When is the payment date for Revvity's (RVTY) latest quarterly dividend?
What is the record date for Revvity's Q2 2025 dividend?